TheraRadar
← Back
Data updated: Mar 29, 2026

NOVAST LABS

OncologyDermatologyCardiovascular
Generics

NOVAST LABS is a generic drug manufacturer focused on Oncology, Dermatology, Cardiovascular.

2008
Since
71
Drugs
-
Trials
379
Approved (2yr)

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 39%
7 drugs
Dermatology 22%
4 drugs
Cardiovascular 22%
4 drugs
Immunology 11%
2 drugs
Gastroenterology 6%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...